Does aluminium have a pathogenic role in dialysis associated arthropathy?

نویسندگان

  • P Netter
  • M Kessler
  • A Gaucher
  • B Bannwarth
چکیده

Annals of the RHEUMATIC DISEASES Leader Does aluminium have a pathogenic role in dialysis associated arthropathy? Dialysis has improved the prognosis and quality of life for patients with chronic renal insufficiency, but at the price of various complications. The first to be recognised were the acute myoclonic encephalopathies,' 2 whose main cause is aluminium overload. This overload results from the use of phosphate binding gels containing aluminium to lower the hyperphosphataemia of these patients, and also from dialysis solutions with a high aluminium content. The incidence of this syndrome has decreased dramatically since the lowering of aluminium concentrations in dialysis solutions and the monitoring of plasma aluminium concentrations in these patients. Nevertheless, some patients still have altered cerebral function related to moderate aluminium overload.3 Other complications can arise in patients receiving long term dialysis,4 5 including hypochromic anaemia6 and osteomalacia.7 The common factor in these complications is the toxicity of aluminium to the organs and tissues affected. Thus aluminium can induce encephalopathies in rats,8 and its tropism for the grey matter of the central nervous system in man has been shown.' Similarly, this element can inhibit bone mineralisation9; it is toxic to osteoblasts and accumulates at the mineralisation front of bone in patients undergoing dialysis.5 9 Indirect evidence of the toxicity of aluminium is the improvement in neurological, haemato-logical, and bony disorders produced by the chelator desferrioxamine. In particular this chelator enhances the activity oferythrocyte (and probably brain) dihydropteridine reductase, and improves the psychomotor function of the patient receiving long term haemodialysis.3 Dialysis associated arthropathy Certain osteoarticular complications of long term haemo-dialysis were recognised early. 1'12 These include epiphysial necrosis, septic or microcrystalline arthritis, lesions of hyperparathyroidism, and tendon ruptures. The increased survival times of patients undergoing haemodialysis have more recently shown a set of manifestations'-'8 described under the term 'dialysis associated arthropathy'. This crippling disorder affects a large number of patients after 10 years of haemodialysis. It is expressed clinically by carpal tunnel syndrome, often bilateral and recurrent, or destructive arthropathies affecting the spine and limbs. Radiographs typically show erosive spondyloarthropathy and juxta-articular cystic lesions of the limbs, predominantly in the wrists, shoulders, knees, and hips. The histological aspects are highly polymorphous, varying with the joint and the patient, so that division of dialysis associated arthropathy into several subgroups has been suggested.'7 Nevertheless, a particular amyloidosis consisting of 02 microglobulin amyloid'9 20 iS often involved in compression of the …

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Silicon and aluminium interactions in haemodialysis patients.

BACKGROUND Aluminium toxicity in dialysis patients is well described. Aluminium has a close chemical affinity with silicon. Silicon may have a role in protection against aluminium toxicity. METHODS We measured serum aluminium and silicon levels from haemodialysis patients from four different centres. RESULTS Though no relationship was seen across all centres combined, in one centre there wa...

متن کامل

DEVELOPMENT OF A METHOD FOR ALUMINIUM DETERMINATION IN SERUM AND DIALYSIS FLUID BY FLAMELESS ATOMIC ABSORPTION WITH GRAPHITE FURNACE

Aluminium determination was carried out in serum and dialysis fluid by a simple and reliable method of nameless atomic absorption with graphite furnace . . No preparatory procedures are required for water and dialysis fluid. In this method serum was mixed with 0.2% HNO, to allow complete combustion of the samples in order to improve analytical precision. The method has a sensitivity of 15 p...

متن کامل

Amyloid, advanced glycation end products, and dialysis related arthropathy.

Dialysis associated arthropathy (DRA) is a syndrome peculiar to long term dialysis patients. It includes large and small joint symptoms, pathological fractures through bony cysts and an axial spondyloarthropathy, and is closely associated with carpal tunnel syndrome. It is characterised by deposition of â2 microglobulin (â2M) as an amyloid protein. This was first linked to the osteoarticular sy...

متن کامل

Sevelamer does not have a distinct melting point. Differential Scanning Calorimetry

Treatment of hyperphosphataemia consists of dietary phosphorus restriction and/or dialysis and phosphate binders. Almost all dialysis patients require phosphate binders (calcium acetate, calcium carbonate, aluminium hydroxide). The use of calcium-based phosphate binders can result in chronic calcium overload, hypercalcemia and soft tissue calcification. Hypercalcemia is particularly common in p...

متن کامل

Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?

BACKGROUND Aluminium-containing phosphate binders have long been used for treatment of hyperphosphatemia in dialysis patients. Their safety became controversial in the early 1980's after reports of aluminium related neurological and bone disease began to appear. Available historical evidence however, suggests that neurological toxicity may have primarily been caused by excessive exposure to alu...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Annals of the rheumatic diseases

دوره 49 8  شماره 

صفحات  -

تاریخ انتشار 1990